Back
Surmodics 10K Form
Sell
27
SRDX
Surmodics
Last Price:
29.23
Seasonality Move:
8.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-08-02 | 10Q | SRDX/Surmodics Quarterly |
2023-04-26 | 10Q | SRDX/Surmodics Quarterly |
2023-02-06 | 10Q | SRDX/Surmodics Quarterly |
2022-07-27 | 10Q | SRDX/Surmodics Quarterly |
2022-04-27 | 10Q | SRDX/Surmodics Quarterly |
2022-02-04 | 10Q | SRDX/Surmodics Quarterly |
Receive SRDX News And Ratings
See the #1 stock for the next 7 days that we like better than SRDX
SRDX Financial Statistics
Sales & Book Value
Annual Sales: | $132.58M |
---|---|
Cash Flow: | $-9.51M |
Price / Cash Flow: | 41.22 |
Annual Sales: | $8.58 |
Price / Book: | 3.37 |
Profitability
EPS (TTM): | 0.38000 |
---|---|
Net Income (TTM): | $5.52M |
Gross Margin: | $61.02M |
Return on Equity: | 4.89% |
Return on Assets: | 3.1% |
Surmodics Earnings Forecast
Key Surmodics Financial Ratios
- The Gross Profit Margin over the past 26 years for SRDX is 46.03%.
- The Selling, General & Administrative Expenses for SRDX have been equal to 39.13% of Gross Profit Margin.
- The Research & Development expenses have been 52.91% of Revenue.
- The Interest Expense is -227.15% of Operating Income.
- The Net Earning history of SRDX is -1.16% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 14 years.
Surmodics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Medical Devices |
Sector: | Healthcare |
Current Symbol: | SRDX |
CUSIP: | 868873 |
Website: | surmodics.com |
Debt
Debt-to-Equity Ratio: | 0.24 |
---|---|
Current Ratio: | 4.84 |
Quick Ratio: | 3.75 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |